These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 872096)

  • 21. Adriamycin and the heart.
    Henderson IC; Frei TE
    N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure.
    Lou H; Danelisen I; Singal PK
    J Mol Cell Cardiol; 2004 May; 36(5):683-90. PubMed ID: 15135663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat].
    Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A
    G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adriamycin cardiomyopathy in a child with Wilms tumor and liver metastases (author's transl)].
    Stopfkuchen H; Gutjahr P
    Klin Padiatr; 1976 Sep; 188(5):459-63. PubMed ID: 184344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adriamycin cardiotoxicity].
    Recalcatri F; Villa A; Belli C
    G Ital Cardiol; 1982; 12(8):612-6. PubMed ID: 7169160
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice.
    Bruynzeel AM; Vormer-Bonne S; Bast A; Niessen HW; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):509-14. PubMed ID: 17177067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthracycline cardiomyopathy in children: report of two cases.
    Mosijczuk AD; Ruymann FB; Mease AD; Bernier RD
    Cancer; 1979 Nov; 44(5):1582-7. PubMed ID: 291472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of 4'-iodo-4'-deoxydoxorubicin-induced cardiotoxicity in two experimental rat models.
    Podestà A; Della Torre P; Pinciroli G; Iatropoulos MJ; Brughera M; Mazué G
    Toxicol Pathol; 1994; 22(1):68-71. PubMed ID: 8073224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiotoxicity of cytostatics in long-term therapy].
    Bühner R
    Dtsch Med Wochenschr; 1978 Aug; 103(33):1311-2. PubMed ID: 98313
    [No Abstract]   [Full Text] [Related]  

  • 33. [Doxorubicin-induced cardiomyopathy].
    Czarnecki A
    Pol Tyg Lek; 1983 Apr; 38(15):471-3. PubMed ID: 6356084
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardial injury induced by a single dose of adriamycin: an electron microscopic study.
    Lambertenghi-Deliliers G; Zanon PL; Pozzoli EF; Bellini O
    Tumori; 1976; 62(5):517-28. PubMed ID: 1020054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.
    Kushner JP; Hansen VL; Hammar SP
    Cancer; 1975 Nov; 36(5):1577-84. PubMed ID: 172214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats.
    To H; Ohdo S; Shin M; Uchimaru H; Yukawa E; Higuchi S; Fujimura A; Kobayashi E
    J Pharm Pharmacol; 2003 Jun; 55(6):803-10. PubMed ID: 12841941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187.
    Zhang J; Herman EH; Ferrans VJ
    Am J Pathol; 1993 Jun; 142(6):1916-26. PubMed ID: 8506959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.
    Wakasugi S; Wada A; Hasegawa Y; Nakano S; Shibata N
    J Nucl Med; 1992 Feb; 33(2):208-14. PubMed ID: 1732442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.